NCT04141020View on ClinicalTrials.gov

Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

November 1, 2026

Study Completion Date

November 1, 2026

Conditions
Cerebral Aneurysm
Interventions
PROCEDURE

Microsurgical clipping

Standard of care microsurgical clipping of an unruptured cerebral artery aneurysm.

PROCEDURE

Endovascular treatment

Standard of care endovascular treatment of an unruptured cerebral artery aneurysm.

DRUG

Sirolimus

Daily oral Sirolimus 2 mg tablets, adjusted as necessary per treating physician.

Trial Locations (1)

33136

RECRUITING

University of Miami, Miami

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Miami

OTHER